Biopolymer hybrid gel-depot delivery system
AssigneePolymers Crc Ltd.
InventorsDavid Edward Mainwaring, Mohammad Al Kobaisi, Brendon Yew Loong Chua, David Charles Jackson, Weiguang Zeng
Life of this patent
Estimating the term…
Loading patent…
AssigneePolymers Crc Ltd.
InventorsDavid Edward Mainwaring, Mohammad Al Kobaisi, Brendon Yew Loong Chua, David Charles Jackson, Weiguang Zeng
Estimating the term…
The invention relates to biopolymer-gel based depot systems for prolonged and/or controlled release delivery of biologically active agents, methods for the manufacture of the biopolymer based gel-depots which include a biologically active agent, and uses of such biopolymer gel-depots in therapy. The biopolymer-gel based depot systems comprise a biocompatible polyaminosaccharide and/or protein; a biocompatible phosphate and/or sulphonamide compound; a biologically active agent; an aqueous insoluble alkaline earth metal phosphate; and a biocompatible glycan and/or proteoglycan.
A prolonged release and/or controlled release delivery system for delivery of a biologically active agent, the system comprising:
3-5. (canceled)
(canceled)
13-19. (canceled)
A method of forming a prolonged release and/or controlled release biopolymer hybrid gel-depot including a biologically active agent, said method comprising:
23-26. (canceled)
A biopolymer hybrid gel-depot comprising:
A biopolymer hybrid gel-depot comprising:
29-34. (canceled)
A method of delivering a biologically active agent to a subject including the step of administering:
A method of delivering a biologically active agent to a subject including the step of implanting a biopolymer hybrid gel-depot comprising:
(canceled)
Dependencies are inferred from the claim text.